Panel Discussion: IgA Nephropathy: Current Achievements, Unmet Needs, & Research Priorities
Time: 8:30 am
day: Pre-Conference Focus Day
Details:
- Explore a comprehensive overview of breakthroughs in IgAN therapies that improve renal outcomes. How far have we come in slowing disease progression and reducing proteinuria?
- Despite advancements, where do gaps still persist? Distil the limitations of existing therapies, variability in patient responses, and the challenges of predicting long-term outcomes. What hurdles remain for patients and clinicians?
- What complexities do standard-of-care treatments (e.g., corticosteroids, calcineurin inhibitors) introduce to clinical trials of innovative therapies for glomerular diseases? Discuss ethical and regulatory considerations in designing trials that balance patient welfare and the need for novel treatment exploration.
- Where should the research community focus next? From addressing personalized medicine approaches to exploring new biomarkers, what areas hold the greatest potential for advancing care and transforming the treatment landscape for IgAN and other glomerular diseases?